Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities

Natalizumab (Tysabri) is a monoclonal antibody (α4 integrin antagonist) approved for treatment of multiple sclerosis, both for patients who fail therapy with other disease modifying agents and for patients with aggressive disease. Natalizumab is highly effective, resulting in significant decreases i...

Descripción completa

Detalles Bibliográficos
Autores principales: Honce, Justin M., Nagae, Lidia, Nyberg, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592919/
https://www.ncbi.nlm.nih.gov/pubmed/26483978
http://dx.doi.org/10.1155/2015/809252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592919/
https://www.ncbi.nlm.nih.gov/pubmed/26483978
http://dx.doi.org/10.1155/2015/809252

Ejemplares similares